Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

Previously, we described an oncolytic vesicular stomatitis virus variant pseudotyped with the nonneurotropic glycoprotein of the lymphocytic choriomeningitis virus, VSV-GP, which was highly effective in glioblastoma. Here, we tested its potency for the treatment of ovarian cancer, a leading cause of...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Molecular Therapy: Oncolytics
المؤلفون الرئيسيون: Catherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, Lisa Egerer, Alexander Muik, Lydia Bellmann, Heidelinde Fiegl, Christian Marth, Janine Kimpel, Dorothee von Laer
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Elsevier 2016-01-01
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2372770516300584